Viewing Study NCT00110227



Ignite Creation Date: 2024-05-05 @ 11:42 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00110227
Status: COMPLETED
Last Update Posted: 2017-02-27
First Post: 2005-05-04

Brief Title: Tai Chi Mind-Body Therapy for Chronic Heart Failure
Sponsor: Beth Israel Deaconess Medical Center
Organization: Beth Israel Deaconess Medical Center

Study Overview

Official Title: Tai Chi Mind-Body Therapy for Chronic Heart Failure
Status: COMPLETED
Status Verified Date: 2017-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: NEXT-Heart
Brief Summary: The purpose of this study is to determine the effects of a tai chi exercise program on functional capacity and health-related quality of life in patients with chronic heart failure HF This study will also examine the way tai chi influences mental physical and social functioning
Detailed Description: HF is a major public health problem in the United States affecting approximately 5 million adults Despite recent advances in pharmacologic therapy and technologic devices HF is the most common reason for hospitalization among Medicare patients and is reaching epidemic proportions as the population ages New and inexpensive interventions that can improve functional capacity and quality of life and can delay disease progression are needed Tai chi is a popular mind-body exercise that is a potential treatment for heart disease This exercise incorporates both gentle physical activity and meditation and it may be particularly suited to frail patients with HF This study will examine the effects of a tailored tai chi program on functional capacity and quality of life in patients with HF

Participants will be randomly assigned to either a tai chi program or heart health education for 12 weeks Participants in both groups will undergo a bicycle stress test at study entry and will receive weekly training sessions of their assigned intervention Self-report scales and questionnaires will be used to assess participants at study start and at the end of 12 weeks

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
R01AT002454 NIH None httpsreporternihgovquickSearchR01AT002454